National Comprehensive Cancer Network

About NCCN

NCCN Introduces Venous Thromboembolic Disease Guidelines

JENKINTOWN, Pa., April 4, 2006 — The National Comprehensive Cancer Network (NCCN) today announces the release of the new NCCN Venous Thromboembolic (VTE) Disease Guidelines. These guidelines outline the diagnosis, treatment and prevention of VTE—a potentially serious condition that occurs when a blood clot forms in the deep veins of the legs or in the pelvic veins. Cancer patients are especially at risk for VTE, which can result in serious complications like pulmonary embolism if not diagnosed and treated effectively. As a result, NCCN has included VTE as part of The NCCN Clinical Practice Guidelines in Oncology™, which are widely recognized and applied as the standard for clinical policy in oncology in both the community practice setting and in academic cancer centers. These guidelines are updated continually and are based upon evaluation of scientific data integrated with expert judgment.

The interest in and concern about VTE has increased dramatically in the last few years. Physicians need a resource that outlines new and effective diagnostic techniques and therapeutic strategies not only for VTE, but also to prevent pulmonary embolism, said Lawrence D. Wagman, M.D., Chair of the VTE Panel and Director of the Liver Tumor Program at City of Hope Cancer Center. The VTE Panel represents the united expertise of medical professionals, including hematologists, oncologists, pharmacologists and cardiologists. Together, we created this detailed guideline for physicians that helps them anticipate and treat VTE, a condition that many cancer patients are at risk for developing.

For more information about the VTE Guideline, please go to

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Cancer Institute
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital